Literature DB >> 12783984

Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study.

J Rico-Sanz1, T Rankinen, D R Joanisse, A S Leon, J S Skinner, J H Wilmore, D C Rao, C Bouchard.   

Abstract

The associations of the C34T polymorphism of the adenosine monophosphate deaminase 1 (AMPD1) gene with cardiorespiratory phenotypes were tested during cycling exercise at absolute and relative power outputs progressing to exhaustion before and after endurance training for 20 wk in the HERITAGE Family Study cohort (n = 779). Since no blacks were mutant homozygotes (TT), only whites were considered for analysis (400 normal homozygotes, CC; 97 heterozygotes, CT; and 6 TT). For sedentary state, cycling at the absolute power output of 50 W resulted in a higher rating of perceived exertion in TT (P < 0.0001). At the relative intensity of 60% of Vo(2 max), stroke volume was lower in TT (P < 0.05). Maximal values for power output, systolic blood pressure, heart rate, Vco(2), and respiratory exchange ratio were lower in TT (P < 0.05). The cardiorespiratory training response at 50 W and at 60% of Vo(2 max) was similar across C34T-AMPD1 genotypes. However, the maximal values for ventilation, Vo(2), and Vco(2) during exercise increased less in TT (P < 0.01). The results indicate that subjects with the TT genotype at the C34T AMPD1 gene have diminished exercise capacity and cardiorespiratory responses to exercise in the sedentary state. Furthermore, the training response of ventilatory phenotypes during maximal exercise is more limited in TT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783984     DOI: 10.1152/physiolgenomics.00165.2002

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  22 in total

Review 1.  Genes and human elite athletic performance.

Authors:  Daniel G Macarthur; Kathryn N North
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

2.  C34T mutation of the AMPD1 gene in an elite white runner.

Authors:  A Lucia; M A Martin; J Esteve-Lanao; A F San Juan; J C Rubio; J Oliván; J Arenas
Journal:  Br J Sports Med       Date:  2006-03       Impact factor: 13.800

Review 3.  Endurance exercise performance: the physiology of champions.

Authors:  Michael J Joyner; Edward F Coyle
Journal:  J Physiol       Date:  2007-09-27       Impact factor: 5.182

4.  The effect of AMPD1 genotype on blood flow response to sprint exercise.

Authors:  Barbara Norman; Anders T Nygren; Jacek Nowak; Richard L Sabina
Journal:  Eur J Appl Physiol       Date:  2008-01-26       Impact factor: 3.078

Review 5.  The genetics of sports injuries and athletic performance.

Authors:  Nicola Maffulli; Katia Margiotti; Umile Giuseppe Longo; Mattia Loppini; Vito Michele Fazio; Vincenzo Denaro
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

6.  C34T mutation of the AMPD1 gene in an elite white runner.

Authors:  Alejandro Lucia; Miguel A Martin; Jonathan Esteve-Lanao; Alejandro F San Juan; Juan C Rubio; Jesús Oliván; Joaquín Arenas
Journal:  BMJ Case Rep       Date:  2009-01-23

7.  Metabolic disorders of purine metabolism affecting the nervous system.

Authors:  H A Jinnah; Richard L Sabina; Georges Van Den Berghe
Journal:  Handb Clin Neurol       Date:  2013

Review 8.  Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction.

Authors:  Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2009-01-29       Impact factor: 1.655

9.  The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes.

Authors:  Ildus I Ahmetov; Alun G Williams; Daniil V Popov; Ekaterina V Lyubaeva; Albina M Hakimullina; Olga N Fedotovskaya; Irina A Mozhayskaya; Olga L Vinogradova; Irina V Astratenkova; Hugh E Montgomery; Viktor A Rogozkin
Journal:  Hum Genet       Date:  2009-12       Impact factor: 4.132

10.  Similarity of polygenic profiles limits the potential for elite human physical performance.

Authors:  Alun G Williams; Jonathan P Folland
Journal:  J Physiol       Date:  2007-09-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.